46 related articles for article (PubMed ID: 35985255)
21. Current insights on clinical efficacy of roflumilast for treatment of COPD, asthma and ACOS.
Bodkhe S; Nikam M; Sherje AP; Khan T; Suvarna V; Patel K
Int Immunopharmacol; 2020 Nov; 88():106906. PubMed ID: 33182057
[TBL] [Abstract][Full Text] [Related]
22. Phosphodiesterase 4 inhibitors in inflammatory bowel disease: a comprehensive review.
Salari-Sharif P; Abdollahi M
Curr Pharm Des; 2010; 16(33):3661-7. PubMed ID: 21128899
[TBL] [Abstract][Full Text] [Related]
23. An evaluation of roflumilast and PDE4 inhibitors with a focus on the treatment of asthma.
Al-Sajee D; Yin X; Gauvreau GM
Expert Opin Pharmacother; 2019 Apr; 20(5):609-620. PubMed ID: 30722707
[TBL] [Abstract][Full Text] [Related]
24. Phosphodiesterase inhibitors in the treatment of inflammatory diseases.
Page CP; Spina D
Handb Exp Pharmacol; 2011; (204):391-414. PubMed ID: 21695650
[TBL] [Abstract][Full Text] [Related]
25. Phosphodiesterase inhibitors in airways disease.
Fan Chung K
Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
[TBL] [Abstract][Full Text] [Related]
26. The discovery of roflumilast for the treatment of chronic obstructive pulmonary disease.
Cazzola M; Calzetta L; Rogliani P; Matera MG
Expert Opin Drug Discov; 2016 Jul; 11(7):733-44. PubMed ID: 27169612
[TBL] [Abstract][Full Text] [Related]
27. PDE4 Inhibition and Inflammatory Bowel Disease: A Novel Therapeutic Avenue.
Spadaccini M; D'Alessio S; Peyrin-Biroulet L; Danese S
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28617319
[TBL] [Abstract][Full Text] [Related]
28. Roflumilast: a selective phosphodiesterase 4 inhibitor.
Christie P
Drugs Today (Barc); 2005 Oct; 41(10):667-75. PubMed ID: 16389409
[TBL] [Abstract][Full Text] [Related]
29. New therapeutic options in the management of COPD - focus on roflumilast.
Antoniu SA
Int J Chron Obstruct Pulmon Dis; 2011; 6():147-55. PubMed ID: 21468165
[TBL] [Abstract][Full Text] [Related]
30. PDE4 inhibitors: a review of current developments (2005 - 2009).
Pagès L; Gavaldà A; Lehner MD
Expert Opin Ther Pat; 2009 Nov; 19(11):1501-19. PubMed ID: 19832118
[TBL] [Abstract][Full Text] [Related]
31. Phosphodiesterase 4 (PDE4) Inhibitors in the Treatment of COPD: Promising Drug Candidates and Future Directions.
Parikh N; Chakraborti AK
Curr Med Chem; 2016; 23(2):129-41. PubMed ID: 26572614
[TBL] [Abstract][Full Text] [Related]
32. Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease.
Chong J; Leung B; Poole P
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD002309. PubMed ID: 28922692
[TBL] [Abstract][Full Text] [Related]
33. PDE4-inhibitors: a novel, targeted therapy for obstructive airways disease.
Diamant Z; Spina D
Pulm Pharmacol Ther; 2011 Aug; 24(4):353-60. PubMed ID: 21255672
[TBL] [Abstract][Full Text] [Related]
34. Phosphodiesterase 4 inhibitors in diabetic nephropathy.
Ookawara M; Nio Y
Cell Signal; 2022 Feb; 90():110185. PubMed ID: 34785349
[TBL] [Abstract][Full Text] [Related]
35. Advances in the Development of Phosphodiesterase-4 Inhibitors.
Peng T; Qi B; He J; Ke H; Shi J
J Med Chem; 2020 Oct; 63(19):10594-10617. PubMed ID: 32255344
[TBL] [Abstract][Full Text] [Related]
36. PDE4 inhibitors as new anti-inflammatory drugs: effects on cell trafficking and cell adhesion molecules expression.
Sanz MJ; Cortijo J; Morcillo EJ
Pharmacol Ther; 2005 Jun; 106(3):269-97. PubMed ID: 15922015
[TBL] [Abstract][Full Text] [Related]
37. Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease.
Chong J; Leung B; Poole P
Cochrane Database Syst Rev; 2013 Nov; (11):CD002309. PubMed ID: 24190161
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of phosphodiesterase 4 inhibitors in patients with asthma: A systematic review and meta-analysis.
Luo J; Yang L; Yang J; Yang D; Liu BC; Liu D; Liang BM; Liu CT
Respirology; 2018 May; 23(5):467-477. PubMed ID: 29502338
[TBL] [Abstract][Full Text] [Related]
39. Phosphodiesterase 4 and its inhibitors in inflammatory diseases.
Jin SL; Ding SL; Lin SC
Chang Gung Med J; 2012; 35(3):197-210. PubMed ID: 22735051
[TBL] [Abstract][Full Text] [Related]
40. [Phosphodiesterase-4 inhibitors: roflumilast].
Izquierdo Alonso JL
Rev Clin Esp; 2011 Mar; 211 Suppl 2():22-30. PubMed ID: 21596170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
